Who are Capacity Bio's investors?

Capacity Bio's investors include Remiges Ventures, Inc., Insight Partners, RA Capital, AN Venture Partners, RDiscovery.

How much funding has Capacity Bio raised?

Capacity Bio has disclosed $19.2M raised across 1 round.

Where is Capacity Bio headquartered?

Capacity Bio is headquartered in Palo Alto, US.

Capacity Bio

Palo Alto, US · Founded 2021 · Delaware corporation · 7 employees on LinkedIn · 5 known investors

Capacity Bio is a biotechnology company developing mitophagy modulators — small molecules, peptides, and nanoparticles that target mitochondrial biology to identify and clear dysfunctional mitochondria. Its pipeline includes a first-in-class mitophagy agonist intended for therapeutic use in aging- and disease-related conditions.

Biotech Deep Tech Longevity

Founders & leadership

Amy WangPhD

Kenneth Horne inNamed on SEC filingManaging Partner at AN Venture Partners

Dylan MorrisNamed on SEC filing

Cristina GhenoiuNamed on SEC filing

Board

Taro Inaba inBoard directorManaging Partner at Remiges Ventures, Inc.

Ken Horne

Investors · 5

Remiges Ventures, Inc.✓ verifiedSeattle

Insight Partners✓ verifiedNew York · $120M – $350M

RA Capital✓ verifiedBoston

AN Venture PartnersTokyo

RDiscoveryTokyo

Reported raises · per SEC filings

Form D private placements

$19.2M disclosed across 1 round · 2022

▶$19.2MraisedJan 2023 · 13 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Kenneth HorneExecutive Officer, Director
Taro InabaDirector
Dylan MorrisDirector
Amy WangExecutive Officer, Director
Cristina GhenoiuDirector

Offering amount: $35.3M
Amount sold: $19.2M
First sale: Dec 2022
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

KALA BIO3 shared keywords

Companies competing with Capacity Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Capacity Bio | Investment | Insight Partnersinsightpartners.com · Jul 2023

Capacity Bio Raises $35 Million Financing to Advance Mitochondria Platform - Global Genesglobalgenes.org · Apr 2023

Frequently asked questions

What does Capacity Bio do?: Capacity Bio is a biotechnology company developing mitophagy modulators — small molecules, peptides, and nanoparticles that target mitochondrial biology to identify and clear dysfunctional mitochondria. Its pipeline includes a first-in-class mitophagy agonist intended for therapeutic use in aging- and disease-related conditions.
Who are Capacity Bio's investors?: Capacity Bio's investors include Remiges Ventures, Inc., Insight Partners, RA Capital, AN Venture Partners, RDiscovery.
How much funding has Capacity Bio raised?: Capacity Bio has disclosed $19.2M raised across 1 round.
Where is Capacity Bio headquartered?: Capacity Bio is headquartered in Palo Alto, US.